Streetbeat News

Products Services

STIM

Neuronetics, Inc. (NASDAQ:STIM) has announced enhancements to its TrakStar Patient Data Management System, a proprietary, HIPAA-compliant, patient management and outcomes reporting system for NeuroStar transcranial magnetic stimulation (TMS) providers. The update introduces automated features to improve communication between providers and patients, and to save practices time in recording and documenting results. This is the second significant upgrade to the platform this year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:23 pm

F

Ford has hired Peter Stern, former Apple Vice President of Services, to lead the newly formed Ford Integrated Services. Stern will report to Ford President and CEO Jim Farley and will focus on integrating hardware, software, and services across Ford Blue, Model e, and Ford Pro. The move is part of Ford's strategy to transform the company by building sustained customer relationships and capturing new, high-margin services, subscription, and digital revenue.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:21 pm

GP

GreenPower Motor Company Inc. (NASDAQ:GP) reported Q1 FY24 revenue of $17.58 million, a 356% Y/Y increase, beating the consensus of $16.33 million. The company delivered 131 vehicles in Q1, most of which were various models of EV Star and BEAST school buses. GP secured a $15 million order from the state of West Virginia for 41 school buses. GP shares are trading higher by 1.99% at $4.12 premarket.

Portfolio Pulse from Nabaparna Bhattacharya

August 14, 2023 | 1:14 pm

GVP

GSE Systems, Inc. (GVP) has won two simulation awards totaling $4M. The first award, worth $2.5M, is for upgrading and integrating plant simulation models for a large, advanced reactor. The second award, worth $1.5M, is for qualifying and delivering a software-based reactor coolant system to support thermohydraulic models for a large international power industry supplier. This is a significant advancement in GSE's proprietary JADE JTopMeret simulation technology.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:11 pm

CNSP

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) has presented updated results from its ongoing study of Berubicin in adult patients with recurrent Glioblastoma Multiforme (GBM). The study is potentially pivotal for the treatment of GBM. The data was presented at the 2023 SNO/ASCO CNS Cancer Conference. The company remains optimistic about Berubicin's potential as a novel and effective therapy for GBM. The FDA has granted CNS Pharmaceuticals Fast Track Designation for Berubicin, which expedites the development and review process.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:10 pm

SLNA

Selina Hospitality PLC (NASDAQ:SLNA) has announced its expansion to the Mediterranean with a new location in Evia, Greece. The new location, Selina Kaminos Evia, is a wellness retreat offering a unique blend of a laid-back atmosphere, locally-inspired design, and innovative wellness programs. The hotel aims to support the local economy and community by providing job opportunities and promoting sustainability.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:07 pm

HRYU

Hanryu Holdings has partnered with SALTLUX to develop an AI-powered conversational virtual assistant for its popular K-culture fandom application, FANTOO.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:07 pm

RTX

RTX has provided Blue Canyon satellites for a NASA swarm test launch. The collaboration between RTX and NASA could potentially lead to more opportunities for RTX in the future.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 1:07 pm

MYMD

The FDA has accepted MyMD Pharmaceuticals' Investigational New Drug Application for a Phase 2 study of oral TNF-α inhibitor MYMD-1 in rheumatoid arthritis. The drug, which has shown promising results in Phase 2 studies for sarcopenia, could disrupt the $41 billion industry. The company is also advancing 3 clinical programs for MyMD-1 in chronic inflammatory conditions including Sarcopenia, RA and Hashimoto's Thyroiditis.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:06 pm

NMRD

Nemaura Medical, Inc. (NASDAQ:NMRD) has released its financial results for Q1 2024, reporting cash and cash equivalents of approximately $4M as of June 30, 2023. The company also announced that it secured an additional $6.5M in clean debt on August 11, 2023. Other highlights include initial patient data from the UK NHS Miboko Study showing weight loss in all participants, continued development of its consumer metabolic health platform, and ongoing work with Benchmark Electronics Inc for future volume scale-up manufacture.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 1:05 pm